TCT: No Benefit From Longer Antiplatelet Tx (CME/CE)

SAN FRANCISCO (MedPage Today) -- Prolonged dual antiplatelet therapy (DAPT) after percutaneous coronary intervention did not have any clinical benefit -- and may have increased bleeding -- in two randomized trials of patients with mostly stable coronary artery disease. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/11/tct-no-benefit-from-longer-antiplatelet.html